Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Number of holders
-
421
-
Total 13F shares, excl. options
-
14,520,329
-
Shares change
-
-571,173
-
Total reported value, excl. options
-
$3,729,151,326
-
Value change
-
-$155,020,766
-
Put/Call ratio
-
221%
-
Number of buys
-
203
-
Number of sells
-
-174
-
Price
-
$257.34
Significant Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q2 2016
532 filings reported holding IBB - ISHARES TR - ISHARES BIOTECH as of Q2 2016.
ISHARES TR - ISHARES BIOTECH (IBB) has 421 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14,520,329 shares
.
Largest 10 shareholders include BANK OF AMERICA CORP /DE/ (2,582,870 shares), GOLDMAN SACHS GROUP INC (1,697,174 shares), BNP PARIBAS ARBITRAGE, SA (1,364,430 shares), CITIGROUP INC (1,080,525 shares), MORGAN STANLEY (871,975 shares), UBS Group AG (550,849 shares), JPMORGAN CHASE & CO (542,729 shares), SG Americas Securities, LLC (245,310 shares), SOCIETE GENERALE (245,310 shares), and CITADEL ADVISORS LLC (213,729 shares).
This table shows the top 421 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.